Grindeks                                                       16.11.2005.



JSC Grindeks information about the tender of shares of company Jelfa 



According to the unofficial information being at disposal of JSC Grindeks 

about the tender of the block of shares in the polish pharmaceutical company 

Jelfa, there were four bidders, including JSC Grindeks, taking part at the 

second stage of the tender. The biggest sum offered for the purchase of the 

block of the shares of PF Jelfa S.A. was offered by the Lithuanian 

pharmaceutical company Sanitas.



On the 5 October this year  Polish Industrial Development Agency (IDA) invited 

JSC Grindeks to submit its second price offer to the tender of acquisition of 

47,83% share capital of the pharmaceutical company Jelfa S.A.

JSC Grindeks applied for the tender, this time submitting price offer 

PLN 73 per share.



Valdis Jakobsons, Chairman of the Management Board, giving comments on the 

offer price per share, pointed out: “Already for a year we are having a 

good cooperation with this company in contract manufacture of the injection 

forms of our originator product Mildronate. During this year we get to know

well company Jelfa and we have developed our standpoint about the value of 

this enterprise and what is the price we are ready to pay for it.”

 

Information prepared by:

Janis Romanovskis

Finance and Administrative director, JSC Grindeks

Tel: 7083250

e-mail: jromanovskis@grindeks.lv